Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms

View source ↗

Summary

This clinical trial investigates the mechanism of action of interferon in the treatment of myeloproliferative neoplasms and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon Alfa (interferon alfa)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Myeloproliferative Neoplasm | Status: RECRUITING